Attached files

file filename
EX-99.2 - EX-99.2 - VEECO INSTRUMENTS INCveco-20200507xex99d2.htm
8-K - 8-K - VEECO INSTRUMENTS INCveco-20200507x8k.htm

EXHIBIT 99.1

 

A picture containing drawing

Description generated with very high confidence

 

VEECO REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

 

First Quarter 2020 Highlights:

 

·

Revenues of $104.5 million, compared with $99.4 million in the same period last year

·

GAAP net loss of $0.6 million, or $0.01 loss per diluted share

·

Non-GAAP net income of $10.9 million, or $0.22 per diluted share

 

Plainview, N.Y., May 7, 2020 -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its first quarter ended March 31, 2020. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release. 

 

 

  U.S. Dollars in millions, except per share data

 

 

 

 

 

 

 

 

GAAP Results

 

Q1 '20

 

Q1 '19

Revenue

 

$

104.5

 

$

99.4

Net income (loss)

 

$

(0.6)

 

$

(18.5)

Diluted earnings (loss) per share

 

$

(0.01)

 

$

(0.40)

 

 

 

 

 

 

 

 

Non-GAAP Results

 

Q1 '20

 

Q1 '19

Net income (loss)

 

$

10.9

 

$

(6.4)

Operating income (loss)

 

$

12.7

 

$

(4.8)

Diluted earnings (loss) per share

 

$

0.22

 

$

(0.14)

 

 

“Our employees around the world have exhibited great professionalism and flexibility as they adapt to working from home or new health and safety measures in our facilities. It is because of their efforts that Veeco has been managing well through the COVID-19 pandemic,” commented William J. Miller, Ph.D., Chief Executive Officer. “Our supply chain, manufacturing and service operations have been successful in maintaining our ability to source materials, ship products and provide support for our customers with only minor disruptions.”

 

“Our semiconductor technologies enable a variety of important megatrends that are expected to perform well, such as cloud and high-performance computing, AI and 5G RF,” continued Dr. Miller.  “In the first quarter, sales were strong in our Data Storage market driven by demand in cloud computing. We improved gross margin and reduced operating expenses, driving solid Non-GAAP EPS. Furthermore, our cash balance, quality of our backlog and the cost reductions we realized over the last several quarters give me confidence in our ability to weather uncertainties we may face.”

 

 

 

 

 

 

 

 

 

 

 

 

1

Guidance and Outlook

 

Given the level of uncertainty resulting from the COVID-19 pandemic, Veeco is refraining from providing Q2 guidance.

 

Conference Call Information

 

A conference call reviewing these results has been scheduled for today, May 7, 2020 starting at 4:30pm ET. To join the call, dial 1-866-288-0540 (toll free) or 1-646-828-8143 and use passcode 9821676. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

 

About Veeco

 

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

 

Forward-looking Statements

 

To the extent that this news release discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the risks discussed in the Business Description and Management's Discussion and Analysis sections of Veeco's Annual Report on Form 10-K for the year ended December 31, 2019 and in our subsequent quarterly reports on Form 10-Q, current reports on Form 8-K and press releases. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

 

 

 

-financial tables attached-

 

Veeco Contacts:

 

Investors: Media:

Anthony Bencivenga (516) 252-1438Kevin Long (516) 714-3978

abencivenga@veeco.com    klong@veeco.com

2

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)
(unaudited)

 

 

 

 

 

 

 

 

 

 

Three months ended March 31,

 

 

    

2020

    

2019

 

Net sales

 

$

104,502

 

$

99,371

 

Cost of sales

 

 

58,083

 

 

64,655

 

Gross profit

 

 

46,419

 

 

34,716

 

Operating expenses, net:

 

 

 

 

 

 

 

Research and development

 

 

19,195

 

 

23,340

 

Selling, general, and administrative

 

 

18,304

 

 

19,902

 

Amortization of intangible assets

 

 

3,837

 

 

4,218

 

Restructuring

 

 

625

 

 

1,430

 

Other operating expense (income), net

 

 

(109)

 

 

(34)

 

Total operating expenses, net

 

 

41,852

 

 

48,856

 

Operating income (loss)

 

 

4,567

 

 

(14,140)

 

Interest expense, net

 

 

(4,866)

 

 

(4,200)

 

Income (loss) before income taxes

 

 

(299)

 

 

(18,340)

 

Income tax expense (benefit)

 

 

268

 

 

190

 

Net income (loss)

 

$

(567)

 

$

(18,530)

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

Basic

 

$

(0.01)

 

$

(0.40)

 

Diluted

 

$

(0.01)

 

$

(0.40)

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

Basic

 

 

47,811

 

 

46,848

 

Diluted

 

 

47,811

 

 

46,848

 

 

3

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

    

2020

    

2019

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

162,325

 

$

129,294

Restricted cash

 

 

652

 

 

657

Short-term investments

 

 

79,429

 

 

115,252

Accounts receivable, net

 

 

84,251

 

 

45,666

Contract assets

 

 

14,612

 

 

25,351

Inventories

 

 

129,611

 

 

133,067

Deferred cost of sales

 

 

1,981

 

 

445

Prepaid expenses and other current assets

 

 

16,446

 

 

14,966

Assets held for sale

 

 

11,183

 

 

11,180

Total current assets

 

 

500,490

 

 

475,878

Property, plant and equipment, net

 

 

72,291

 

 

75,711

Operating lease right-of-use assets

 

 

13,159

 

 

14,453

Intangible assets, net

 

 

57,680

 

 

61,518

Goodwill

 

 

181,943

 

 

181,943

Deferred income taxes

 

 

1,549

 

 

1,549

Other assets

 

 

5,774

 

 

7,036

Total assets

 

$

832,886

 

$

818,088

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

36,359

 

$

21,281

Accrued expenses and other current liabilities

 

 

41,568

 

 

41,243

Customer deposits and deferred revenue

 

 

49,628

 

 

54,870

Income taxes payable

 

 

954

 

 

830

Total current liabilities

 

 

128,509

 

 

118,224

Deferred income taxes

 

 

5,763

 

 

5,648

Long-term debt

 

 

303,388

 

 

300,068

Operating lease long-term liabilities

 

 

9,294

 

 

10,300

Other liabilities

 

 

8,868

 

 

9,336

Total liabilities

 

 

455,822

 

 

443,576

 

 

 

 

 

 

 

Total stockholders’ equity

 

 

377,064

 

 

374,512

Total liabilities and stockholders’ equity

 

$

832,886

 

$

818,088

4

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)
(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

 

 

 

 

 

 

Share-Based

 

 

 

 

 

 

 

 

Three months ended March 31, 2020

    

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

 

Net sales

 

$

104,502

 

 

 

 

 

 

 

$

104,502

 

Gross profit

 

 

46,419

 

521

 

 

 

21

 

 

46,961

 

Gross margin

 

 

44.4

%

 

 

 

 

 

 

 

44.9

%

Operating expenses

 

 

41,852

 

(3,125)

 

(3,837)

 

(667)

 

 

34,223

 

Operating income (loss)

 

 

4,567

 

3,646

 

3,837

 

688

^

 

12,738

 

Net income (loss)

 

 

(567)

 

3,646

 

3,837

 

3,935

^

 

10,851

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.01)

 

 

 

 

 

 

 

$

0.23

 

Diluted

 

 

(0.01)

 

 

 

 

 

 

 

 

0.22

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

47,811

 

 

 

 

 

 

 

 

47,811

 

Diluted

 

 

47,811

 

 

 

 

 

 

 

 

48,437

 


^- See table below for additional details.

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)
(unaudited)

 

 

 

Three months ended March 31, 2020

    

 

Restructuring

 

625

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

63

Subtotal

 

688

Non-cash interest expense

 

3,320

Non-GAAP tax adjustment *

 

(73)

Total Other

 

3,935


*- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

5

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)
(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

 

 

 

 

 

 

Share-based

 

 

 

 

 

 

 

Three months ended March 31, 2019

    

 

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

 

Net sales

 

$

99,371

 

 

 

 

 

 

 

$

99,371

 

Gross profit

 

 

34,716

 

470

 

 

 

47

 

 

35,233

 

Gross margin

 

 

34.9

%  

 

 

 

 

 

 

 

35.5

%

Operating expenses

 

 

48,856

 

(2,687)

 

(4,218)

 

(1,967)

 

 

39,984

 

Operating income (loss)

 

 

(14,140)

 

3,157

 

4,218

 

2,014

^

 

(4,751)

 

Net income (loss)

 

 

(18,530)

 

3,157

 

4,218

 

4,787

^

 

(6,368)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.40)

 

 

 

 

 

 

 

$

(0.14)

 

Diluted

 

 

(0.40)

 

 

 

 

 

 

 

 

(0.14)

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

46,848

 

 

 

 

 

 

 

 

46,848

 

Diluted

 

 

46,848

 

 

 

 

 

 

 

 

46,848

 


^- See table below for additional details.

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)
(unaudited)

 

 

 

Three months ended March 31, 2019

 

 

Restructuring

    

1,430

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

142

Accelerated depreciation

 

397

Other

 

45

Subtotal

 

2,014

Non-cash interest expense

 

3,081

Non-GAAP tax adjustment *

 

(308)

Total Other

 

4,787


*- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

6

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)

(in thousands)
(unaudited)

 

 

 

 

 

 

 

 

    

Three months ended

    

Three months ended

 

 

March 31, 2020

 

March 31, 2019

GAAP Net income (loss)

 

$

(567)

 

$

(18,530)

Share-based compensation

 

 

3,646

 

 

3,157

Amortization

 

 

3,837

 

 

4,218

Restructuring

 

 

625

 

 

1,430

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

 

63

 

 

142

Accelerated depreciation

 

 

 —

 

 

397

Interest (income) expense, net

 

 

4,866

 

 

4,200

Other

 

 

 —

 

 

45

Income tax expense (benefit)

 

 

268

 

 

190

Non-GAAP Operating income (loss)

 

$

12,738

 

$

(4,751)

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

7